Viral glycoprotein metabolism as a target for antiviral substances.
D000998:Antiviral Agents / Q000494:pharmacology*; D001692:Biological Transport / Q000187:drug effects; D002258:Carbonyl Cyanide m-Chlorophenyl Hydrazone / Q000494:pharmacology; D003847:Deoxyglucose / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D004721:Endoplasmic Reticulum / Q000378:metabolism; D000939:Epitopes; D019788:Fluorodeoxyglucose F18; D005944:Glucosamine / Q000494:pharmacology; D006023:Glycoproteins / Q000276:immunology / Q000378:metabolism*; D006561:Herpes Simplex / Q000188:drug therapy; D006801:Humans; D006835:Hydrazones / Q000494:pharmacology; D009844:Oligosaccharides / Q000378:metabolism; D010447:Peptide Hydrolases / Q000378:metabolism; D014415:Tunicamycin / Q000494:pharmacology; D014759:Viral Envelope Proteins; D014764:Viral Proteins / Q000276:immunology / Q000378:metabolism*; D014780:Viruses / Q000187:drug effects* / Q000254:growth & development
D000998:Antiviral Agents; D000939:Epitopes; D006023:Glycoproteins; D006835:Hydrazones; D009844:Oligosaccharides; D014759:Viral Envelope Proteins; D014764:Viral Proteins; D019788:Fluorodeoxyglucose F18; D014415:Tunicamycin; D002258:Carbonyl Cyanide m-Chlorophenyl Hydrazone; C027566:benzhydrazone; D003847:Deoxyglucose; D010447:Peptide Hydrolases; D005944:Glucosamine